天立國際控股(01773.HK)獲執行董事、主席兼行政總裁羅實增持213.5萬股
格隆匯8月29日丨天立國際控股(01773.HK)發佈公告,董事會獲公司執行董事、主席兼行政總裁羅實通知,2025年8月28日,羅先生於公開市場交易購買合共213.5萬股,佔公司已發行股份總數約0.10%,平均價格爲每股股份約港幣3.68元。緊隨購買後,羅先生直接及間接持有本公司共約9.05億股股份,佔公司於本公告日期已發行股份總數約42.93%。同日,公司於公開市場交易回購267.2萬股股份,佔公司已發行股份總數約0.13%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.